MRD-POSITIVE
Clinical trials for MRD-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new MRD-POSITIVE trials appear
Sign up with your email to follow new studies for MRD-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR-T cells take on donor infusion in battle against stubborn leukemia
Disease control Recruiting nowThis study tests whether a powerful immune cell therapy (CAR-T) works better than standard donor immune cells (DLI) to wipe out leftover leukemia in patients who had a stem cell transplant. About 70 people aged 3 to 80 with a certain type of leukemia and minimal residual disease …
Matched conditions: MRD-POSITIVE
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for leukemia patients: drug targets hidden cancer cells after transplant
Disease control Recruiting nowThis study tests a drug called Inotuzumab Ozogamicin (INO) in people with acute lymphoblastic leukemia (ALL) who still have tiny amounts of leukemia cells (called minimal residual disease, or MRD) after a stem cell transplant. The goal is to see if INO can clear these leftover ce…
Matched conditions: MRD-POSITIVE
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated May 20, 2026 11:56 UTC